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Abstract (250 words) 
 
Context: Breathlessness, fatigue, and anxiety are distressing symptoms for patients with 
advanced lung cancer. Usually managed as isolated symptoms, they can often occur 
simultaneously. Previous research has often addressed management of discrete 
symptoms rather than considering them as a cluster, which in reality is the situation faced 
by patients. 
 
Objectives: This study aims to examine the effectiveness of a psychoeducational 
intervention (PEI) on the symptom cluster of anxiety, breathlessness and fatigue, 
compared with usual care. 
 
Methods: A pre-test post-test 2-group randomized controlled trial was conducted. 
Education on symptom management and coaching in the use of progressive muscle 
relaxation were delivered to patients one week prior to commencing radiotherapy (RT), 
and repeated 3 weeks after the first.  Symptom data were collected at 4 time points: prior 
to the intervention, 3 weeks, 6 weeks, and 12 weeks post intervention.  
 
Results: 140 lung cancer patients receiving palliative RT were recruited from a public 
funded hospital in Hong Kong.  Doubly multivariate MANOVA revealed a significant 
difference (Time *group interaction effect, p = .003) over time between the PEI and 
usual care control group on the pattern of change of the symptom cluster.  Significant 
effects on the patterns of changes in breathlessness (p = .002), fatigue (p = .011), anxiety 
(p = .001) and functional ability (p = .000) were also found.  
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Conclusions:  PEI was a promising treatment for relieving the symptom cluster and each 
of the individually assessed symptoms. More effort needs to be directed at studying 
impact of interventions on common symptom clusters.   
 
Key words: symptom cluster, breathlessness, fatigue, anxiety, psychoeducational 
intervention, progressive muscle relaxation, advanced lung cancer 
 
Running title: Managing symptoms in patients with advanced lung cancer during 
radiotherapy: results of a psychoeducational randomized controlled trial 
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INTRODUCTION 
 
Lung cancer is the leading cancer diagnosis for both genders in Hong Kong.
1
   The 
majority of patients with lung cancer presents with either advanced disease or develop 
metastases soon after the initial diagnosis.  Although radiation treatment (RT) can 
manage endobronchial or extrinsic lesions of lung cancer and lengthen a patient’s life,2  it 
can also cause severe side effects that compromise quality of life.  Patients with 
advanced lung cancer undergoing RT are particularly vulnerable to the symptoms of 
breathlessness, fatigue and anxiety
3-5
 which impact on patient function.
6-8
   
 
Patients with lung cancer often experience symptoms concurrently and they usually have 
overlapping and interactive effects.
 9,10
 A symptom cluster is defined as three or more 
concurrent symptoms that are moderately correlated with each other.
 11
   Providing an 
intervention aimed at treating a symptom cluster as a whole could lead to greater 
effectiveness and efficiency, which potentially maximizes the use of clinicians’ as well 
as patients’ efforts. 
 
Although the concept of symptom clusters is now acknowledged to be at the cutting edge 
of science in symptom management,
12,13
  few published accounts of trials of 
interventions attempt to treat symptoms together as a cluster.  Early in 1995, Lenz et al. 
published a theory of unpleasant symptoms that focused on explaining the impact of 
experiencing multiple symptoms.
14
  This theory laid a foundation for the trend to now 
research the treatment of multiple symptoms simultaneously. Given et al.’s8 study 
demonstrated the ‘value-added’ role of a psychoeducational intervention (PEI) in 
reducing overall symptom burden of 12 common symptoms.   In 2004, Given et al.
15
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conducted a similar study demonstrating the positive effect of a PEI on 15 symptoms.  
However, these studies did not test or define the multiple symptoms as a cluster, in other 
words, the association and concurrent existence of these symptoms were not tested. 
 
A recent review indicated that the intensity of a symptom cluster, comprising 
breathlessness, fatigue, and anxiety worsens during RT, and these symptoms cluster 
together in patients treated with RT.
5,16 
 There are several studies that demonstrate 
correlations and similarities between breathlessness, fatigue and anxiety.
16-18
  For 
instance, stress is identified as a common trigger for all these symptoms.
19
 The episode 
of breathlessness, fatigue and anxiety usually begins with a trigger which is either 
physical or emotional stress. 
3, 16-19
 Physical stress includes pain, labored breathing while 
emotional stress may include fear, worry, and anger.   
 
Psycho-educational interventions (PEIs) intend to prepare patients for the symptom 
experience, to clarify misconceptions, to alleviate stress and negative affects, to enhance 
a sense of control over the illness, and to promote self-care practice. 
6,8,15
  In the last few 
decades, large numbers of studies evaluating PEI in patients with cancer have been 
conducted. 
12
  Progressive muscle relaxation (PMR) appears to be the most prevalent 
intervention to be studied, followed by patient education.  While PEI has been advocated 
to manage cancer symptoms, breathlessness and fatigue appear to be neglected and 
understudied symptoms.    Despite the reported benefits of PEI in the management of 
anxiety, there have been fewer studies of PEI in patients with lung cancer, in contrast to 
other cancers. 
19
  In addition, no research has been reported to date on the impact of PEI 
on the intensity and distress generated by these symptoms, when considered as a cluster.  
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Reduced patient functioning is considered as a common outcome of symptom 
experience, as advocated by several theories and models.
 9, 10
  This phenomenon is also 
supported by empirical evidence. 
7, 11
 An important research question is whether relief of 
symptom clusters promotes patients’ function.  Researchers have recommended that 
function be studied as an outcome of interventions directed at a symptom cluster, and 
emphasized the desirability of conducting symptom cluster research on homogenous 
samples and in a particular culture.
7,20
 In this study, the authors developed and tested a 
psychoeducational intervention (PEI) comprising patient education and PMR for relief of 
the common cluster of breathlessness, fatigue, and anxiety. 
 
AIMS 
 
The aim of the study was to examine the effectiveness of a PEI combining patient 
education and progressive muscle relaxation (PMR), compared with a usual care control 
group on a symptom cluster involving anxiety, breathlessness and fatigue in patients with 
advanced lung cancer receiving palliative radiotherapy. 
 
Hypothesis: 
 
There will be a significant difference in the pattern of change over time between the PEI 
and usual care groups in lung cancer patients presenting with the symptom cluster of 
anxiety, breathlessness, and fatigue. 
 
METHODS 
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Setting and subjects: A pre-test post-test 2-group randomized controlled trial was 
conducted in an outpatient RT unit of a public funded hospital in Hong Kong. All 
patients attending the RT department were approached to consider participating and in 
order to assess eligibility. A total of 140 subjects were recruited and consented to the 
study.   
 
Anxiety was selected as a major outcome for the purpose of sample estimation, as 
anxiety (ES ranging from 0.3-0.8) is the most frequently measured variable for 
determining the efficacy of PMR and PEI..
21
 A medium ES was used to calculate the 
sample size. Given an estimated attrition rate of 10% and based on the original sample 
estimate of 64, the sample size needed per group was 70.  Patients were randomized by 
lucky draw method to either an intervention group or control group. 
 
Inclusion criteria of subjects were as follows:  
1. age 16 or above 
2. stage 3 or 4 lung cancer and to receive palliative radiotherapy (RT)  of an average of 
4.3 Grays/fraction 
3. the ability to communicate in Chinese 
4. signed informed consent 
5. an abbreviated mental test score of 8 or above indicating normal cognitive ability 
6. A Karnofsky Performance Status scores of 60% or above, indicating they are capable 
of some self care and not bedridden.  
Exclusion criteria: Patients with known psychiatric morbidity and /or involvement in 
other clinical trials. 
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Outcome measures: 
 
Primary outcome measures 
Breathlessness  
Patients’ subjective experience of the intensity of breathlessness was assessed through a 
100 mm visual analogue scale.  VAS has been used in previous studies and shown to be 
a sensitive tool through which to assess the subjective experience of breathlessness.
6
 
Fatigue 
The intensity subscale of the revised Piper Fatigue Scale (PFS)
22
 consists of 23 items 
directed at measuring intensity of fatigue.  Reliability and validity have been 
established.
22
  The instrument has been translated into Chinese and found to be valid and 
reliable (0.97 alpha coefficient).
23
 
Anxiety  
The Chinese version of the A-State scale of the State-Trait Anxiety Inventory (STAI)
24
 
was used to assess state anxiety.  The A-state scale consists of 20 items for measuring 
immediate feelings of apprehension, nervousness and worry.  A-state has an established 
internal consistency of 0.90.
25
 
Secondary outcome measure 
Functional ability  
The functional ability subscale of the Chinese version (HK) of the SF-36 Health Survey
26
 
was used.  The subscale includes a multi-item scale measuring 4 dimensions: 1) physical 
functioning; 2) role limitation due to physical problem; 3) role limitation due to 
emotional problem; and 4) social functioning.  SF-36 has been shown to be a valid 
measure to assess the effectiveness of PEI.
26
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Baseline demographic/disease/treatment data were obtained from patients and their 
medical records. Patients’ previous experiences on PEI or complementary therapies were 
also assessed. 
  
Intervention 
Breathlessness, fatigue, and anxiety are multifaceted symptoms that comprise cognitive, 
psychological and behavioral components, suggesting a combination of education and 
relaxation may produce a more holistic effect.
4,6,15,28
  Development of the PEI in this 
study was informed by previous research on breathlessness, fatigue and anxiety in cancer 
patients
4,6,29
 and the literature on PEIs.  PEI alters patients’ perception and sensation of 
symptoms through stress reduction; clarification of misconception; and the adoption of 
adaptive behaviors.
30
  The aim of the current intervention was to manage the three 
symptoms together (as a cluster), based on the symptoms’ commonality in that stress 
could aggravate each one of them.
3,4,18,20
  Patients were enabled to adopt adaptive 
behaviors to delay the intensification of symptoms through the following components: 
preparatory information; discussion of symptoms’ experience; exploration of meanings 
of, and goals associated with, symptoms; advice on self-care strategies; and training and 
practice in progressive muscle relaxation (PMR) (see Figure 1). 
 
Insert Figure 1 here.    
 
A 40-minutes educational package plus coaching of PMR was delivered to patients 
within one week prior to the beginning of the course of RT and reinforced three weeks 
after commencing RT.  The education package consisted of leaflets and discussion on the 
selected symptoms and their self-care management (see Appendix 1). The intervention 
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was delivered by registered nurses with 2 years clinical experience. A 2-day training 
session was given to the intervention nurses focusing on the educational package and the 
practice of PMR.  
A Chinese audiotape and educational leaflets were provided to patients. Patients were 
encouraged to practice PMR daily and as required.   Patients in the intervention group 
were given a telephone reminder at the end of the 2
nd
 week to enhance participation in 
the week 3 sessions. 
 
Usual care: The usual care of this study comprised a mandatory individual briefing of 
the RT procedure and about 5-7 minutes discussion of side effects focusing on skin care 
by a therapy radiographer. Patients were also invited to attend an optional group talk 
given by a registered nurse and a medical social worker about general care before or after 
the commencement of RT.  Patients in both intervention and control group were offered 
this usual care. 
 
Patients’ adherence and participation in the intervention 
 
Intervention activity log  
An intervention activity log was set up in which the research assistant (RA) recorded at 
each session problems encountered during implementation of the intervention. The RA 
also recorded patients’ general involvement such as attention span and ability to follow 
instruction.   
Diary  
Patient adherence to the relaxation exercise was recorded in a simple health diary 
(calendar) by patients for 12 consecutive weeks. Health diary is commonly used in 
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clinical research and shown to be a practical and sensitive tool to record health actions 
over time.
27
 
 
Data collection procedure 
Data were collected by a research assistant who was blind to group allocation. Subjects 
were asked to complete all outcome measures before RT commenced and prior to 
randomization (T0) and then at week 3 (T1), week 6 (T2), 3 months (T3).  For maximum 
effect of PMR regular daily practice for 3-6 weeks is necessary.
31,32
  In order to detect 
the full effect of the intervention as well as changes in the intensity of symptoms 
expected to become gradually worse as RT progressed with a peak at around week 3-6,
33
 
and the longer term effects of the intervention some months after RT had finished, a 
repeated measures design was adopted to detect the pattern of changes over time. 
 
Data analysis 
 
Doubly multivariate MANOVA were performed to examine the effect of the PEI on the 
symptom cluster, referred to as a composite outcome comprising the vector of means on 
the transformed scores of breathlessness, fatigue and anxiety across time.  Scores of all 
three symptoms at all time points were positively skewed; therefore, the original scores 
of breathlessness, fatigue, and anxiety were transformed by square root transformations 
to achieve the best distribution of normality. Mixed between-within subjects ANOVA 
compared scores on functional ability between study groups across time.  Missing data at 
T1, T2 and T3 were imputed by a carry forward method based on intention to treat 
analysis. Data were analyzed using Statistics Package for Social Sciences SPSS version 
13.0 for windows. 
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The analyses of changes in outcome variables between T0 – T2 were the main focus, 
data relating to changes between T0-T3 were only assessed in an exploratory manner to 
examine longer term effects. 
 
RESULTS 
 
During the study period, 255 patients with advanced lung cancer were assessed for 
eligibility.  Fifty-nine patients (23%) did not meet the eligibility criteria, mainly due to 
poor scores on the Karnofsky scale and Abbreviated Mental Tests.  Fifty-six patients 
(21%) declined to participate because they were not interested in the study, or because 
they felt they were too tired and/or too ill to participate.  The remaining 140 eligible 
patients consented to participate.  The overall attrition rate was 4% at week 3 (T1), 9% at 
week 6 (T2) and 27% at week 12 (T3).  Patients in the control group (42%) experienced 
higher attrition than the intervention group (11%) at T3. At all time points the sole 
reason for attrition was death.   
 
 Baseline characteristics of the study sample 
 
The majority of patients were male (83%), married (87%), and retired (54%).  Patients’ 
mean scores on the Abbreviated Mental Test (9.43/10) and Karnofsky scores (84/100) 
were high.  Less than half of patients had distant metastasis (46%), co-morbidity (40%), 
or concurrent treatment with chemotherapy (18%).  Patients’ mean duration of cancer 
illness was 4.4 months. The chest and mediastinum were the major sites of RT. 
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The majority of patients (75-80%) had no history of practicing relaxation exercise, 
complementary therapies, or other supportive service.  Less than half (33%) attended the 
usual care group talk which was offered to all study patients.   At baseline, all patients 
had a low intensity for breathlessness (mean =15.81, range 0 – 100), whereas their 
fatigue (mean = 3.41, range 0-10) and anxiety (mean = 42.04, range: 20-80) intensity 
scores were low to moderate.  They had an overall low to moderate functional score 
(mean = 25.14 – 66.41, range 0-100). Patients in the control group had significantly more 
advanced stage of cancer (2 = 4.13, P< .05) as compared to the intervention group. 
Table 1 shows mean symptom scores and functional ability for each study group from 
baseline to week 12. 
 
Insert Table 1 here. 
 
Correlations between outcome variables 
 
Significant and moderate positive intercorrelations between breathlessness, fatigue, and 
anxiety at T0, T1, T2, and T3 were found (p<.01) and all pairs of variables’ associations 
had correlations of <.07.  This supports the use of the MANOVA test as MANOVA 
performs best for variables with moderate strength correlations.  This also underlines the 
clustering of these symptoms.  In addition to the significant intercorrelations between 
these outcome variables, each of the baseline outcome variables also related significantly 
to their respective post-test measurements.  These relationships suggest there was a need 
to consider not only the three outcome variables, but also the repeated time factor as 
multivariate, so the effect of the intervention came to be analyzed by Doubly MANOVA. 
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Outcome evaluation from T0 – T2 
Due to the baseline difference of stage of cancer between the study groups, stage of 
cancer was entered into the model for analysis.  All subsequent analyses included both 
stage of cancer and study groups as independent variables. The non-significant effects of 
the interaction terms time*stage (p>.05) and time*group*stage (p >.05) show that stage 
of cancer did not appear to affect the pattern of change on the symptom cluster and each 
individual variable and the time*group interaction was not different by stage of cancer 
across T0-T3. 
 
Results in Table 2 show that the pattern of change of the composite outcome across the 
study period T0 – T2 was found to be significantly different between the two study 
groups (Time * group interaction effect, p = .003). According to Cohen
34
, the strength of 
Eta Squared values (.14) can be interpreted as a large intervention effect.    
 
Insert Table 2 here. 
  
As a significant result on the multivariate test of significance of the composite outcome 
was found, further investigations (univariate tests) in relation to each of the dependent 
variables of breathlessness, fatigue and anxiety were conducted.  In order to reduce the 
possibility of a Type I error the original alpha level of .05 was divided by 3, giving a new 
alpha level of .017.
35
  
 
Univariate tests on breathlessness showed a significant difference (p =. 002) in the 
pattern of change in breathlessness between the two study groups across T0-T2 (time * 
group effect) with small effect (Partial Eta Squared = .04). There was a significant 
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difference (p =. 011) in the pattern of change in fatigue with a small effect size (Partial 
Eta Squared = .033). In terms of anxiety, again there was a significant difference (p =. 
001) in the pattern of change with small effect (Partial Eta Squared = .051) (see Table 3).  
 
Insert Table 3 here. 
 
 
Mixed between-within subjects ANOVA compared scores on functional ability between 
study groups across T0-T2.  Results in Table 4 show that there was a statistically 
significant effect for time * group interaction (P = .000), suggesting there was a 
significant difference in the pattern of change in scores of functional ability from T0-T2 
for the two groups with moderate effect size (.11). 
 
Insert Table 4 here 
 
Long-term effect of PEI  
 
Due to the high attrition rate (27%) at week 12, the examination of the effect of PEI at 
week 12 (T3) was only exploratory in nature. The pattern of change of the composite 
outcome across the study period T0 – T3 was significantly different between the two 
study groups (Time * group interaction effect) (p = .004). 
 
Univariate tests showed that there was a significant difference in the pattern of change 
(time*group effect) in breathlessness (p =.001) and anxiety (p = .005) between the two 
study groups across T0-T3 with a small effect (Partial Eta Squared = .043 and .035).  No 
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significant difference was found in the pattern of change in fatigue across T0-T3 (p = 
.034).   
 
Mixed between-within subjects ANOVA shows there was a significant difference in the 
pattern of change in scores of functional ability over 12 weeks for the two groups (time * 
group interaction P= .002).  
 
Patients’ adherence to and participation in intervention 
Ninety four percent of subjects in the intervention group completed the intervention in 
full as measured by the intervention log.  The majority demonstrated high attention and 
interest in the intervention. On average, subjects practiced 4-5 times of PMR/week.  
Over 60% of subjects both read the leaflets and listened to the audiotape. 
 
DISCUSSION 
 
Published research on managing symptom clusters in patients with cancer is scant. The 
current study provides support for the management of breathlessness, fatigue, and anxiety 
together as a symptom cluster;  results suggests that PEI interventions provide a promising 
approach for the treatment of multiple symptoms within a cluster simultaneously in this 
group.   
 
Meta-analysis of previous cancer trials of PEI report effect sizes ranging from small to 
moderate, depending on the symptom under investigation and the type of intervention.
28,36
 
Comparisons among effect sizes are difficult to make because of the diversity of 
interventions and study designs. Nevertheless, a major strength of the current study was that 
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the three target symptoms were combined into a single composite outcome (consisting of 
the vector of the means on the scores of breathlessness, fatigue and anxiety).  The composite 
outcome, namely the symptom cluster, was designed to capture the totality of effectiveness 
of the PEI.  The total difference in symptom intensity between the intervention and control 
group might go undetected if each dependent variable were to be examined separately.  
Weinfurt
37
 suggests that comparing differences in the composite outcome is a more 
sensitive approach to detecting intervention effects than comparing individual outcomes.    
An additional strength of measuring this composite outcome was to reduce the risk of Type 
1 error likely to occur when multiple comparisons with the same group of patients are 
conducted.  
 
A further strength is that the study used three independent instruments to measure the 
intensity of the three selected symptoms.  This allows the performance of multivariate tests 
as well as univariate tests (in order to meet the assumption of singularity).  Previous studies 
using combined symptom severity scores as the outcome measure were not suited to 
multivariate testing and unable to identify the effect of the intervention on individual 
symptoms.
8,15
   
 
The current study is one of the few PEI studies conducted in an Asian population with 
cancer. As evidenced by patients’ lack of previous experience in using psychosocial 
orientated interventions and conclusions drawn from previous reviews;
32,38,39
 the application 
of PEI in this context can be considered novel.   The low attendance at the usual care session 
indicates a need for a change to the current service and its delivery mode.  The PEI was 
found to be an acceptable and feasible intervention and appeared to cause no harmful effects 
to patients, even at their advanced stage of disease.  Future developments may consider 
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incorporating PEI as a usual component of practice and evaluating its clinical effects 
through a phase IV study.
40
 
 
In view of the generally poor health status of subjects, it was important that outcome 
measures were concise so as not to overburden patients.  Therefore, the current study 
focused on symptom intensity; other dimensions such as distress, and the impact of 
symptom cluster on patients’ overall quality of life, were not measured.  These could be 
important aspects of outcome measurement in symptom studies. In future studies, 
measuring the distress from dyspnea and other symptoms using a VAS rather than just 
intensity may be an option. However, researchers need to take a balanced view 
combining scientific interest with patient assessment burden.  
 
Cost effectiveness is another important outcome to address in future trials.  The current 
study suggests an add-on value of this PEI.  Costs in the current study mainly concerned 
additional personnel used to deliver the intervention.  Theoretically, this cost could be 
offset by the cost of poor symptom management (such as frequency of hospitalization, 
length of hospital stay, and pharmacological treatments).   Future studies may need to 
explicitly address the issue of resource utilization and cost effectiveness in their design. 
 
Study limitations 
 
The high attrition rate encountered at week 12 was mainly due to death.  Missing data 
were not at random but were related to outcomes that can lead to attrition bias. Finding 
should be viewed with caution due to the missing data. Future study may consider using 
the Palliative Performance Scale  (PPS) 
41 
which may be a more reliable predictor than 
 20 
the Karnofsky in estimating how long a patient can be enrolled in a study.  Second, more 
patients in the control group had a more advanced stage of cancer and distant metastasis.  
Although stage of cancer did not significantly affect the outcome differences between 
study groups, this revealed a failure in the randomization process.    In relation to study 
design, a placebo group was not employed. An attention placebo group would have 
served to achieve blinding of subjects and detect the effects of attention, whilst the usual 
care group compares the intervention effect with existing service.  There is also little 
information on patients’ perceptions and feelings towards the process and outcome of the 
intervention.  Qualitative interviews may be useful in future studies to solicit this 
information 
 
CONCLUSION 
 
The results of the study suggest that the PEI was a promising treatment for relieving this 
symptom cluster and each of the individually assessed symptoms at week 6 after 
palliative RT, as well as improving patients’ functional ability.  The long-term effect of 
PEI on the symptom cluster at week 12 was inconclusive.  The study provides evidence 
for the assessment and management of breathlessness, fatigue and anxiety, as a symptom 
cluster. Findings are encouraging and add to the theoretical body of knowledge on cancer 
symptom management.  Researchers are encouraged to advance the theory, measurement 
and management of symptom clusters, especially in relation to clarifying the mechanism 
of inter-relationship among symptoms within a cluster, and to investigate treatment 
interventions. 
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Clinically, it is prudent for clinicians to view some symptoms as a cluster where they 
influence, and will be influenced, by each other.  Managing a cluster, rather than 
individual symptoms, should be regarded as a contemporary approach in the provision of 
effective and efficient cancer and palliative care.  
 22 
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Figure 1 Analytical model depicting the relationship between the intervention and outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Independent variable: Psychoeducational intervention 
  
Cognitive component      Psychological component     Behavioral component 
 
 
Preparatory 
information 
 Advice on self care strategies 
 Training and practice of PMR 
 Discussion of the symptoms 
 Exploration of meanings of and 
goals associated with the symptoms 
Primary outcomes 
 
Symptom cluster of  
 Fatigue 
 Anxiety 
 Breathlessness                                              
Secondary outcome 
 
 Functional ability 
 
 
Dependent variables 
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Appendix 1 
Protocol for educational intervention 
 
An interactive educational session is delivered by nurse research assistant.  This package of 
intervention aims at reassuring the patients that something can be done to help them cope with 
their side effects. Content of the package include:  
(1) preparatory information on the possible and prominent symptoms focusing on 
breathlessness, fatigue, and anxiety.   
(2) discussion of symptoms and factors that ameliorate or exacerbate them;  
(3) exploration of the meaning of breathlessness, fatigue and anxiety and their feeling about 
them;  
(4) advice and support for patients on self care strategies of managing those symptoms.  
 
Patients are allowed to have time to ask questions and have the opportunity for repeated 
information in an unhurried manner.  
The package is supplemented by 4 Chinese leaflets focusing on understanding the symptoms 
and patients’ self care in managing those symptoms. 
Leaflet 1: Coping with breathlessness  
Cause of breathlessness: destruction of lung tissue by tumor, pleural effusion, 
increased mucus secretion, weakness of abdominal and chest muscles, anxiety, fear 
Self care: smoking cessation, new breathing technique (slow deep breaths through 
pursed lips), positioning, relaxation exercise, cool air, means of dealing with 
frightening thoughts during respiratory distress 
Leaflet 2: Coping with fatigue 
Cause of fatigue: demands of cancer and the treatment, feeling sick and other 
symptoms, loss of appetite, infection or fever, anxiety, depression, stress 
Self care: rescheduling of day-to-day activities, nutritious diet, mild exercise, sleep 
enhancement, relaxation exercise 
Leaflet 3: Coping with anxiety 
Cause of anxiety: physical changes or side-effects of the treatment, disability, 
breathlessness and fear of suffocation 
Self care: relaxation exercise, ventilation of feelings, meditation, support group 
Leaflet 4: Guide for progressive muscle relaxation   
 
An audiotape of all information corresponding to that in the leaflet is provided to all 
participants.  Information of the leaflet/audiotape is derived from literature and the 
publications produced by Hong Kong Cancer fund and Cancerbacup (permission to use the 
material was obtained from both organizations). All the educational materials have been 
reviewed by an expert panel composed of radiologists and nurse specialists. The readability of 
the leaflets is at the educational level of primary six.  This has been tested on 10 persons with 
primary six level of education to ensure its readability.  
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Table 1: Mean scores and standard deviations of breathlessness, fatigue, anxiety and 
functional ability in each study group from baseline to week 12 
 
Grouping N 
Range 
of scale Mean Std. Deviation 
Baseline breathing  Control 70  
 
 
 
0-100 
20.386 22.4501 
  Intervention 70 17.114 17.8614 
Week 3 breathing  Control 66 34.000 26.7634 
  Intervention 69 18.855 19.8689 
Week 6 breathing  Control 59 31.356 25.3539 
  Intervention 68 19.103 23.1163 
Week12 breathing  Control 40 30.778 30.2399 
  Intervention 62 19.855 26.9540 
Baseline fatigue  Control 70  
 
 
 
0-10 
4.4262 2.84993 
  Intervention 70 3.8024 2.64077 
Week 3 fatigue  Control 66 4.8939 2.96700 
  Intervention 69 3.5145 2.91221 
Week 6 fatigue  Control 59 4.9831 2.99995 
  Intervention 68 3.1887 2.62181 
Week 12 fatigue  Control 40 3.9708 2.81249 
  Intervention 62 3.2581 2.79387 
Baseline anxiety  Control 70  
 
 
 
20-80 
43.2429 10.58771 
  Intervention 70 42.8286 10.39505 
Week 3 anxiety  Control 66 43.6212 11.76274 
  Intervention 69 42.1304 11.51459 
Week 6 anxiety  Control 59 44.5424 11.95007 
  Intervention 68 39.2500 10.24094 
Week 12 anxiety  Control 40 40.6500 11.29908 
  Intervention 62 39.8065 10.36362 
Baseline functional ability  Control 70  
 
 
 
0-100 
53.0149 27.07606 
  Intervention 70 50.3393 27.14660 
Week 3 functional ability Control 66 46.9255 30.55070 
  Intervention 69 51.6697 30.20989 
Week 6 functional ability Control 59 44.1702 30.44309 
  Intervention 68 57.5123 27.69611 
Week 12 functional ability  Control 40 53.4948 33.05262 
  Intervention 62 56.3508 31.44884 
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Table 2: Multivariate test results with study group and stage of cancer as independent variables across 
T0-T2 
 
 Pillai’s Trace 
Value 
F Sig. Partial Eta 
Squared 
Observed 
Power 
GROUP .083 4.064 .008 .083 .835 
STAGE .045 2.092 .104 .045 .525 
TIME .084 2.005 .069 .084 .715 
TIME * 
GROUP 
.138 3.485 .003 .138 .939 
TIME * 
STAGE 
.019 .426 .861 .019 .172 
TIME* 
GROUP* 
STAGE 
.032 .725 .630 .032 .279 
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Table 3: Univariate test on transformed breathlessness, fatigue and anxiety from T0 – T2 with study 
group and stage of cancer as independent variables 
Breathlessness 
 Type III Sum 
of Squares 
df Mean 
Square 
F Sig. Partial Eta 
Squared 
Observed 
Power 
GROUP 3.553 1 3.553 7.368 .007 .051 .769 
STAGE .009 1 .009 .018 .893 .000 .052 
TIME 1.691 2 .866 5.845 .004 .041 .865 
TIME* 
GROUP 
1.814 2 .928 6.269 .002 .044 .888 
TIME * 
STAGE 
.336 2 .172 1.160 .314 .008 .251 
TIME* 
GROUP* 
STAGE 
.193 2 .099 .667 .511 .005 .160 
Fatigue 
 Type III Sum 
of Squares 
df Mean 
Square 
F Sig. Partial Eta 
Squared 
Observed 
Power 
GROUP 14.315 1 14.315 11.116 .001 .076 .912 
STAGE 2.403 1 2.403 1.866 .174 .014 .274 
TIME .028 2 .015 .051 .944 .000 .058 
TIME* 
GROUP 
2.605 2 1.368 4.681 .011 .033 .768 
TIME * 
STAGE 
.059 2 .031 .106 .891 .001 .066 
TIME* 
GROUP* 
STAGE 
.587 2 .308 1.055 .347 .008 .229 
Anxiety 
 Type III Sum 
of Squares 
df Mean 
Square 
F Sig. Partial Eta 
Squared 
Observed 
Power 
GROUP .072 1 .072 2.582 .110 .019 .358 
STAGE .142 1 .142 5.120 .025 .036 .613 
TIME .001 2 .000 .076 .906 .001 .061 
TIME* 
GROUP 
.065 2 .037 7.246 .001 .051 .909 
TIME * 
STAGE 
.000 2 .000 .029 .959 .000 .054 
TIME* 
GROUP* 
STAGE 
.004 2 .002 .457 .609 .003 .120 
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Table 4: Mixed between-within subjects ANOVA of functional ability from T0-T2 with both study group 
and stage of cancer as independent variables 
 
Effect Sum of 
Squares 
Pillai's 
Trace 
Value 
F Sig. Partial Eta 
Squared 
Observed 
Power 
GROUP 3253.278  1.728 .191 .013 .257 
STAGE 2607.701  1.385 .241 .010 .215 
TIME  .017 1.175 .312 .017 .254 
TIME * GROUP  .108 8.144 .000 .108 .956 
TIME*STAGE  .003 .221 .802 .003 .084 
TIME * 
GROUP* 
STAGE 
 .000 .009 .991 .000 .051 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
